The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral antibacterial agents against respiratory pathogens
Open Access
- 1 April 1998
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 4, 2S8-2S18
- https://doi.org/10.1111/j.1469-0691.1998.tb00690.x
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- A 1994–1995 survey of Haemophilus influenzae susceptibility to ten orally administered agents A 187 clinical laboratory center sample in the United StatesDiagnostic Microbiology and Infectious Disease, 1997
- Effets comparés de la pénicilline, de l'amoxicilline et du céfotaxime in vitro sur Streptococcus pneumoniaeMedecine Et Maladies Infectieuses, 1997
- Management of community-acquired pneumoniaCurrent Opinion in Infectious Diseases, 1996
- Highlights of the French antimicrobial resistance surveillance projectDiagnostic Microbiology and Infectious Disease, 1996
- Prospective study of epidemiology and prognostic factors in community-acquired pneumoniaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibioticsJournal of Antimicrobial Chemotherapy, 1991
- Epidemiology, pathogenesis, and prevention of pneumoniaCurrent Opinion in Infectious Diseases, 1991
- In-vitro activity of amoxycillin/clavulanic acid and five other oral antibiotics against clinical isolates of Haemophilus influenzae and Branhamella catarrhalisJournal of Antimicrobial Chemotherapy, 1988
- Prospective study on the etiology of community-acquired pneumonia in children and adults in SpainEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Emergence of Multiply Resistant PneumococciNew England Journal of Medicine, 1978